Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ETHACRYNIC ACID USP, with a corresponding US DMF Number 26013.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 16, 2013, and payment made on May 03, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II